Showing results (141-150 of 184) with videos related to
Sort By:
Pageof 19
Transplantation and Cellular Therapy|October 16, 2023
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic MalignancyCatherine J Lee, Tao Wang, Karen Chen, et al.Blood|October 18, 2014
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationEffie W Petersdorf, Theodore A Gooley, Mari Malkki, et al.Transplantation and Cellular Therapy|July 6, 2025
Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTRAntonio M Jimenez Jimenez, Stephen R Spellman, Ioannis Politikos, et al.Blood|May 21, 2021
The clinical and functional effects of TERT variants in myelodysplastic syndromeChristopher R Reilly, Mikko Myllymäki, Robert Redd, et al.Blood Advances|August 29, 2019
Multiple functional variants in the <i>IL1RL1</i> region are pretransplant markers for risk of GVHD and infection deathsEzgi Karaesmen, Theresa Hahn, Alexander James Dile, et al.Haematologica|June 2, 2016
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant ResearchAleksandr Lazaryan, Tao Wang, Stephen R Spellman, et al.Blood Advances|March 6, 2025
Transplant Outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR AnalysisKarthik Nath, Mei-Jie Zhang, Matthew Bye, et al.JAMA Oncology|May 2, 2024
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid LeukemiaLaura W Dillon, Gege Gui, Niveditha Ravindra, et al.Bone Marrow Transplantation|November 6, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemiaGege Gui, Niveditha Ravindra, Pranay S Hegde, et al.Transplantation and Cellular Therapy|March 15, 2021
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseCaitlin W Elgarten, Yimei Li, Kelly D Getz, et al.Pageof 19